New York bills · 2025 Regular Session
New York S 9221
Establishes a medetomidine, benzodiazepine, nitazenes, and/or other harmful contaminants test strip program
- Introduced
- In committee
- Passed Senate
- Passed House
- To Governor
- Became law
Sponsors
- Christopher Ryan (Democratic)
Summary
Official abstract published by the New York legislature
Directs the commissioner of the office of alcoholism and substance abuse services to establish a program for individuals to receive free drug test strips to detect the presence of medetomidine, benzodiazepine, nitazenes, and/or other harmful contaminants; directs the commissioner of the office of alcoholism and substance abuse services, in cooperation with the commissioner of the department of health, to develop and conduct a public awareness and educational campaign on the dangers of medetomidine, benzodiazepine, nitazenes, and/or other harmful contaminants.
Text versions
Roll-call votes
State vote data last updated Oct 16, 2026, 4:04 AM.
| Date | Vote | Result | Your legislators |
|---|---|---|---|
| May 21, 2026 Senate | Alcoholism And Substance Use Disorders Vote | pass | Set your home in New York to see |
Actions
- Jun 4, 2026 · Senate
SUBSTITUTED BY A9001 - Jun 4, 2026 · Senate
ORDERED TO THIRD READING CAL.1742 - Jun 4, 2026 · Senate
COMMITTEE DISCHARGED AND COMMITTED TO RULES - May 21, 2026 · Senate
REPORTED AND COMMITTED TO FINANCE - Feb 17, 2026 · Senate
REFERRED TO ALCOHOLISM AND SUBSTANCE USE DISORDERS